Connection

Diane Descamps to Darunavir

Back to Details
This is a "connection" page, showing publications Diane Descamps has written about Darunavir.
Diane Descamps
Connection Strength
0.428
Darunavir
  1. Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis. J Antimicrob Chemother. 2018 04 01; 73(4):1108-1110.
    View in: PubMed
    Score: 0.138
  2. Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet. Sci Rep. 2018 01 15; 8(1):710.
    View in: PubMed
    Score: 0.136
  3. No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir. J Antimicrob Chemother. 2018 Jan 01; 73(1):173-176.
    View in: PubMed
    Score: 0.135
  4. High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial. Clin Infect Dis. 2009 Nov 01; 49(9):1441-9.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.